Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.
Stevens-Johnson Syndrome Antimicrobial
Corneal Epitheliotropic Factors in Autologous Serum Eye Drops in Nonautoimmune and Stevens-Johnson Syndrome With Dry Eye
Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye
Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis
|7||Enrolling by invitation||
Salivary Gland Transplantation in the Treatment of Dry Eye in Patients With Stevens-Johnson Syndrome.
Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation
Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)
Lamictal in the Treatment of Post-Herpetic Neuralgia
|12||Active, not recruiting||
Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell Deficiency
† Indicates status has not been verified in more than two years